Sana Biotechnology, Inc. Common Stock SANA
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-11T14:53:16.313Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:53:09.101532886Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-11T14:53:15.265051+00:00
Sana Biotechnology, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 1.65 | 561.9% | 46.5% | |||
| 25Δ | 1.88 | 454.9% | 36.8% | |||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | 2.39 | 122.9% | 8.6% | |||
| 50Δ | 2.25 | 157.8% | 8.0% | |||
| 55Δ | 2.11 | 192.6% | 7.4% | |||
| 60Δ | 1.97 | 227.5% | 6.8% | |||
| 65Δ | 1.82 | 262.3% | 6.2% | |||
| 70Δ | 1.68 | 297.2% | 5.6% | |||
| 75Δ | 1.54 | 332.0% | 5.0% | |||
| 80Δ | 1.40 | 366.8% | 4.4% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.65
- IV
- 561.9%
- B/E move
- 46.5%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.88
- IV
- 454.9%
- B/E move
- 36.8%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 2.39
- IV
- 122.9%
- B/E move
- 8.6%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 2.25
- IV
- 157.8%
- B/E move
- 8.0%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 2.11
- IV
- 192.6%
- B/E move
- 7.4%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 1.97
- IV
- 227.5%
- B/E move
- 6.8%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 1.82
- IV
- 262.3%
- B/E move
- 6.2%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 1.68
- IV
- 297.2%
- B/E move
- 5.6%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 1.54
- IV
- 332.0%
- B/E move
- 5.0%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 1.40
- IV
- 366.8%
- B/E move
- 4.4%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 126.11% | |
| 107.33% | |
| 143.20% | |
| 151.23% | |
| 145.06% | |
| 136.56% | |
| 145.62% | |
| 153.08% |
Biotechnology
SEPN
Description unavailable
More →SGMT
Description unavailable
More →SION
Description unavailable
More →SLDB
Description unavailable
More →SLN
Description unavailable
More →SLS
SELLAS Life Sciences Group, Inc., an advanced-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for various indications of cancer in the…
More →